Conference Proceedings
Preliminary Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) MM17 Trial: Response Adaptive Salvage Treatment with Carfilzomib-Thalidomide-Dexamethasone (KTd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy
Andrew Spencer, Hang Quach, Noemi Horvath, Ian H Kerridge, Flora Yuen, Edwin Sze-Hung Lee, Edward S Morris, Anna Kalff, Krystal Bergin, Shreerang Sirdesai, Malgorzata Gorniak, Sridurga Mithraprabhu, Tiffany Khong, John Reynolds
Blood | AMER SOC HEMATOLOGY | Published : 2018